Hidradenitis suppurativa – prevalence analyses of German statutory health insurance data
2020; Wiley; Volume: 35; Issue: 1 Linguagem: Inglês
10.1111/jdv.16783
ISSN1468-3083
AutoresSylke Schneider‐Burrus, Gerald Lux, Klaus Linde, Sebastian Barbus, Johannes Huss‐Marp, A. Tsaousi, Jürgen Wasem, B. Wolff, Robert Sabat,
Tópico(s)Autoimmune and Inflammatory Disorders
ResumoJournal of the European Academy of Dermatology and VenereologyVolume 35, Issue 1 p. e32-e35 Letter To The Editor Hidradenitis suppurativa – prevalence analyses of German statutory health insurance data S. Schneider-Burrus, Corresponding Author S. Schneider-Burrus schneiderburrus@havelklinik.de orcid.org/0000-0002-9740-6845 Department for Dermatosurgery, Havelklinik, Berlin, Germany Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this authorG. Lux, Corresponding Author G. Lux gerald.lux@medman.uni-due.de Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, Germany Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this authorK. van der Linde, K. van der Linde Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, GermanySearch for more papers by this authorS. Barbus, S. Barbus AbbVie Deutschland GmbH & Co. KG, Wiesbaden, GermanySearch for more papers by this authorJ. Huss-Marp, J. Huss-Marp AbbVie Deutschland GmbH & Co. KG, Wiesbaden, GermanySearch for more papers by this authorA. Tsaousi, A. Tsaousi Psoriasis Research and Treatment Centre, Charité – Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorJ. Wasem, J. Wasem Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, Germany These authors contributed equally to this work.Search for more papers by this authorB. Wolff, B. Wolff AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany These authors contributed equally to this work.Search for more papers by this authorR. Sabat, Corresponding Author R. Sabat robert.sabat@charite.de Psoriasis Research and Treatment Centre, Charité – Universitätsmedizin Berlin, Berlin, Germany Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany These authors contributed equally to this work. Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this author S. Schneider-Burrus, Corresponding Author S. Schneider-Burrus schneiderburrus@havelklinik.de orcid.org/0000-0002-9740-6845 Department for Dermatosurgery, Havelklinik, Berlin, Germany Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this authorG. Lux, Corresponding Author G. Lux gerald.lux@medman.uni-due.de Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, Germany Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this authorK. van der Linde, K. van der Linde Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, GermanySearch for more papers by this authorS. Barbus, S. Barbus AbbVie Deutschland GmbH & Co. KG, Wiesbaden, GermanySearch for more papers by this authorJ. Huss-Marp, J. Huss-Marp AbbVie Deutschland GmbH & Co. KG, Wiesbaden, GermanySearch for more papers by this authorA. Tsaousi, A. Tsaousi Psoriasis Research and Treatment Centre, Charité – Universitätsmedizin Berlin, Berlin, GermanySearch for more papers by this authorJ. Wasem, J. Wasem Institute for Health Care Management and Research, University Duisburg-Essen, Duisburg, Germany These authors contributed equally to this work.Search for more papers by this authorB. Wolff, B. Wolff AbbVie Deutschland GmbH & Co. KG, Wiesbaden, Germany These authors contributed equally to this work.Search for more papers by this authorR. Sabat, Corresponding Author R. Sabat robert.sabat@charite.de Psoriasis Research and Treatment Centre, Charité – Universitätsmedizin Berlin, Berlin, Germany Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany These authors contributed equally to this work. Correspondence: S. Schneider-Burrus. E-mail: schneiderburrus@havelklinik.de; G. Lux. E-mail: gerald.lux@medman.uni-due.de; R. Sabat. E-mail: robert.sabat@charite.deSearch for more papers by this author First published: 24 June 2020 https://doi.org/10.1111/jdv.16783Citations: 13 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume35, Issue1January 2021Pages e32-e35 RelatedInformation
Referência(s)